OXURION (EBR:OXUR) | WebDisclosure

Basculer en Français

10368	Companies
215928	Keywords
145680	Articles
114360	Press releases

Home
Companies
OXURION

PRESS RELEASE

published on 08/04/2025 at 08:30, 9 months 3 days ago

Oxurion rondt overname van Axiodis CRO af en versnelt uitbouw van haar Europese platform voor klinische data
Oxurion schliesst erfolgreich die Übernahme von 72% des Aktienkapitals von Axiodis CRO ab und beschleunigt die Gespräche mit strategischen Partnern zur Schaffung eines integrierten Plattforms für klinische Daten

Übernahme Partnerschaften Oxurion Axiodis CRO Klinische Daten
BRIEF

published on 07/30/2025 at 18:05, 9 months 8 days ago

Oxurion Réceptionne une Notification de Transparence Modifiée

Actions Transparence Atlas Special Opportunities Oxurion Bio-pharmaceutique
BRIEF

published on 07/30/2025 at 18:05, 9 months 8 days ago

Oxurion Receives a Modified Transparency Notification

Actions Transparency Biopharmaceutical Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 07/30/2025 at 18:00, 9 months 8 days ago

Oxurion ontvangt aangepaste transparantiekennisgeving van Atlas Special Opportunities II LLC
Oxurion NV receives transparency notification from Atlas Special Opportunities II LLC regarding shareholding threshold

Transparency Notification Shareholding Belgium Oxurion NV Atlas Special Opportunities II LLC
PRESS RELEASE

published on 07/30/2025 at 18:00, 9 months 8 days ago

Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV announces receipt of transparency notification on shareholder ownership crossing under threshold due to selling of voting securities. Press release replaces previous announcement

Transparency Notification Biopharmaceutical Oxurion NV Voting Securities Shareholder Ownership
BRIEF

published on 07/25/2025 at 18:05, 9 months 13 days ago

Oxurion Annonce une Augmentation de Capital via Conversion d'Obligations

Augmentation De Capital Biopharmaceutique Actions Ordinaires Atlas Special Opportunities Oxurion
BRIEF

published on 07/25/2025 at 18:05, 9 months 13 days ago

Oxurion Announces Capital Increase via Bond Conversion

Common Shares Capital Increase Biopharmaceuticals Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 07/25/2025 at 18:00, 9 months 13 days ago

Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
Atlas Special Opportunities, LLC convertit 10 obligations convertibles en Oxurion, augmentant le capital de 250 000 EUR. Oxurion reçoit 11 161 618 nouvelles actions pour 250 000 EUR dans le cadre de l'engagement de 20 millions EUR d'Atlas

Innovation Capital Atlas Special Opportunities Oxurion Convertissement
PRESS RELEASE

published on 07/25/2025 at 18:00, 9 months 13 days ago

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Atlas Special Opportunities, LLC converts 10 convertible bonds in Oxurion, resulting in a EUR 250,000 capital increase. Oxurion continues focus on innovative therapeutics for elderly vision preservation

Capital Increase Therapeutics Atlas Special Opportunities Oxurion Vision Preservation
BRIEF

published on 07/24/2025 at 18:05, 9 months 14 days ago

Augmentation du capital d'Oxurion suite à une conversion d'obligations

Capital Biotechnologie Actions Atlas Oxurion

Accesswire

Published on 05/07/2026 at 18:30, 3 hours 6 minutes ago

Silver Storm Announces Mobilization of Underground Mine Development Contractors at La Parrilla
Published on 05/07/2026 at 16:35, 5 hours 1 minute ago

Caledonia Mining Corporation Plc New Corporate Video
Published on 05/07/2026 at 15:15, 6 hours 21 minutes ago

ACCESS Newswire Launches ACCESS Insights & Analytics, AI-Powered Press Release Scoring Platform
Published on 05/07/2026 at 14:35, 7 hours 1 minute ago

Worksport (NASDAQ: WKSP) Announces Q1 2026 Earnings Call Date and Launch of Investor Townhall Series
Published on 05/07/2026 at 14:30, 7 hours 6 minutes ago

Rio Grande Resources Announces Results of First Annual General Meeting and Re-Appointments

View all ACCESSWIRE

EQS Group

Published on 05/07/2026 at 20:42, 54 minutes ago

RHÖN-KLINIKUM AG reports stable development in the first quarter of 2026
Published on 05/07/2026 at 18:46, 2 hours 50 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/07/2026 at 18:35, 3 hours 1 minute ago

Seminole Hard Rock Casino Named Official Miami World Cup 2026™ Host City Supporter
Published on 05/07/2026 at 18:00, 3 hours 36 minutes ago

Correction d’un communiqué du 05.05.2026 21:46 CET/CEST - E-PANGO: Composition du capital au 30 avril 2026
Published on 05/07/2026 at 17:47, 3 hours 49 minutes ago

RM plc: Result of AGM

Les Echos

Published on 05/07/2026 at 19:15, 2 hours 21 minutes ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 2 hours 21 minutes ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 2 hours 30 minutes ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 2 hours 30 minutes ago

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 2 hours 36 minutes ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE